Credit: Getty Images Until semaglutide, weight loss of 15% ... treatment of obesity: STEP 1, the largest trial, compared semaglutide and LI with placebo and LI over 68 weeks.

A trial exploring ... the two doses of semaglutide were comparable, while around a third of patients treated with 7.2mg achieved more than 25% weight loss. "Results from STEP UP further strengthen ...

Findings showed a 13.6% reduction in body weight in the semaglutide 25 mg group compared with a 2.2% reduction in the placebo group.

Once-weekly semaglutide 2.4 mg significantly reduced steatohepatitis and liver fibrosis symptoms among adults with metabolic ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

In this ongoing phase 3, multicenter, randomized, double-blind, placebo-controlled trial ... weekly subcutaneous semaglutide at a dose of 2.4 mg or placebo for 240 weeks. The results of a planned ...

The drug also helped participants with weight loss ... causes, semaglutide offers a promising new approach for millions of patients.” The clinical trial involved participants with moderate to advanced ...

The findings are being hailed as a promising step ... impressive weight-loss benefits, contains the active ingredient semaglutide, also found in diabetes drug Ozempic. The clinical trial, funded ...

Using semaglutide injections, scientists were able to reverse life-threatening cases of liver disease in a new clinical trial published ... as well as 10.5% weight loss. "I've been working with ...